SCHEMBL7741783

SCHEMBL7741783

[C-]#[N+]CCCn1c(Cn2c(=O)n(C3CC3)c(=O)c3ccccc32)nc2ccccc21

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.54
TSHR P16473 4/20 0.45
NPSR1 Q6W5P4 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
CRHBP P24387 1/20 0.45
CRHR2 Q13324 1/20 0.45
ALDH1A1 P00352 3/20 0.44
POLB P06746 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
KMT2A Q03164 1/20 0.39
PTK2B Q14289 1/20 0.37
HPGD P15428 1/20 0.35
GAA P10253 1/20 0.34
ALOX15 P16050 1/20 0.34
RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7745852 0.87 CYP3A4 (0.59) CYP3A4TSHRNPSR1SMN1; SMN2CRHBP
SCHEMBL7746055 0.86 CYP3A4 (0.72) CYP3A4TSHRNPSR1SMN1; SMN2CRHBP
SCHEMBL8366214 0.85 CYP3A4 (0.54) CYP3A4TSHRNPSR1SMN1; SMN2CRHBP
SCHEMBL7741415 0.81 TSHR (0.39) CYP3A4TSHRSMN1; SMN2ALDH1A1POLB
SCHEMBL6479793 0.80 CYP3A4 (0.50) CYP3A4TSHRNPSR1SMN1; SMN2CRHBP
SCHEMBL6783757 0.78 CYP3A4 (0.54) CYP3A4TSHRNPSR1SMN1; SMN2CRHBP
SCHEMBL6247449 0.77 CYP3A4 (0.49) CYP3A4TSHRNPSR1SMN1; SMN2CRHBP
SCHEMBL6274097 0.76 CYP3A4 (0.58) CYP3A4TSHRNPSR1SMN1; SMN2CRHBP
SCHEMBL7891212 0.75 NPSR1 (0.46) CYP3A4TSHRNPSR1SMN1; SMN2CRHBP
SCHEMBL7747798 0.73 MEN1 (0.41) TSHRSMN1; SMN2POLBL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed